POS0825 CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS: A NATIONWIDE DANISH REGISTER-BASED COHORT STUDY

R. Westermann; R. L. Cordtz; K. Duch; L. Mellemkjær; M. L. Hetland; A. M. Burden; O. Hejlesen; M. Bøgsted; L. Dreyer

doi:10.1136/annrheumdis-2023-eular.83

POS0825 CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS: A NATIONWIDE DANISH REGISTER-BASED COHORT STUDY

R. Westermann, R. L. Cordtz, K. Duch, L. Mellemkjær, M. L. Hetland, A. M. Burden, O. Hejlesen, M. Bøgsted, L. Dreyer

Research output: Contribution to journal › Conference abstract in journal › Communication

Original language	English
Article number	POS0825
Journal	Annals of the Rheumatic Diseases
Volume	82
Issue number	Suppl. 1
Pages (from-to)	708-709
Number of pages	2
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2023-eular.83
Publication status	Published - Jun 2023
Event	EULAR 2023 European Congress of Rheumatology - Milan, Italy Duration: 31 May 2023 → 3 Jun 2023 https://congress.eular.org/index.cfm

Conference

Conference	EULAR 2023 European Congress of Rheumatology
Country/Territory	Italy
City	Milan
Period	31/05/2023 → 03/06/2023
Internet address	https://congress.eular.org/index.cfm

Bibliographical note

Abstract no. POS0825

Access to Document

10.1136/annrheumdis-2023-eular.83

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Westermann, R., Cordtz, R. L., Duch, K., Mellemkjær, L., Hetland, M. L., Burden, A. M., Hejlesen, O., Bøgsted, M., & Dreyer, L. (2023). POS0825 CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS: A NATIONWIDE DANISH REGISTER-BASED COHORT STUDY. Annals of the Rheumatic Diseases, 82(Suppl. 1), 708-709. Article POS0825. https://doi.org/10.1136/annrheumdis-2023-eular.83

@article{b9bdba066501493db30ea1f1c1c85de6,

title = "POS0825 CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS: A NATIONWIDE DANISH REGISTER-BASED COHORT STUDY",

author = "R. Westermann and Cordtz, {R. L.} and K. Duch and L. Mellemkj{\ae}r and Hetland, {M. L.} and Burden, {A. M.} and O. Hejlesen and M. B{\o}gsted and L. Dreyer",

note = "Abstract no. POS0825; EULAR 2023 European Congress of Rheumatology ; Conference date: 31-05-2023 Through 03-06-2023",

year = "2023",

month = jun,

doi = "10.1136/annrheumdis-2023-eular.83",

language = "English",

volume = "82",

pages = "708--709",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 1",

url = "https://congress.eular.org/index.cfm",

}

Westermann, R , Cordtz, RL , Duch, K, Mellemkjær, L, Hetland, ML, Burden, AM, Hejlesen, O , Bøgsted, M & Dreyer, L 2023, 'POS0825 CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS: A NATIONWIDE DANISH REGISTER-BASED COHORT STUDY', Annals of the Rheumatic Diseases, vol. 82, no. Suppl. 1, POS0825, pp. 708-709. https://doi.org/10.1136/annrheumdis-2023-eular.83

POS0825 CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS: A NATIONWIDE DANISH REGISTER-BASED COHORT STUDY. / Westermann, R.; Cordtz, R. L.; Duch, K. et al.
In: Annals of the Rheumatic Diseases, Vol. 82, No. Suppl. 1, POS0825, 06.2023, p. 708-709.

Research output: Contribution to journal › Conference abstract in journal › Communication

TY - ABST

T1 - POS0825 CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS: A NATIONWIDE DANISH REGISTER-BASED COHORT STUDY

AU - Westermann, R.

AU - Cordtz, R. L.

AU - Duch, K.

AU - Mellemkjær, L.

AU - Hetland, M. L.

AU - Burden, A. M.

AU - Hejlesen, O.

AU - Bøgsted, M.

AU - Dreyer, L.

N1 - Abstract no. POS0825

PY - 2023/6

Y1 - 2023/6

U2 - 10.1136/annrheumdis-2023-eular.83

DO - 10.1136/annrheumdis-2023-eular.83

M3 - Conference abstract in journal

SN - 0003-4967

VL - 82

SP - 708

EP - 709

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 1

M1 - POS0825

T2 - EULAR 2023 European Congress of Rheumatology

Y2 - 31 May 2023 through 3 June 2023

ER -